MwanzoIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
$ 29.03
Baada ya Saa za Kazi:(0.00%)0.00
$ 29.03
Imefungwa: 22 Apr, 16:01:14 GMT -4 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 28.51
Bei za siku
$ 28.46 - $ 29.31
Bei za mwaka
$ 23.95 - $ 52.34
Thamani ya kampuni katika soko
4.61B USD
Wastani wa hisa zilizouzwa
1.82M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 226.58M | -30.18% |
Matumizi ya uendeshaji wa biashara | 88.08M | 72.67% |
Mapato halisi | -104.35M | -1,026.51% |
Kiwango cha faida halisi | -46.05 | -1,515.79% |
Mapato kwa kila hisa | -0.43 | -464.44% |
EBITDA | -108.12M | -733.19% |
Asilimia ya kodi ya mapato | 2.51% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.30B | -1.48% |
Jumla ya mali | 3.00B | 0.45% |
Jumla ya dhima | 2.42B | -7.22% |
Jumla ya hisa | 588.35M | — |
hisa zilizosalia | 158.96M | — |
Uwiano wa bei na thamani | 7.64 | — |
Faida inayotokana na mali | -9.11% | — |
Faida inayotokana mtaji | -10.65% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -104.35M | -1,026.51% |
Pesa kutokana na shughuli | -116.14M | -453.38% |
Pesa kutokana na uwekezaji | 68.21M | 355.36% |
Pesa kutokana na ufadhili | -44.12M | -208.33% |
Mabadiliko halisi ya pesa taslimu | -92.53M | -296.01% |
Mtiririko huru wa pesa | -113.03M | -268.37% |
Kuhusu
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza, Tegsedi, and Waylivra, and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.
The company was named Isis Pharmaceuticals until December 2015. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1989
Makao Makuu
Tovuti
Wafanyakazi
1,069
